Enterococcus durans endocarditis in a patient with transposition of the great vessels

Journal of Medical Microbiology

Volumn 53, Issue 3, 2004, Pages 259-261

  Stepanovic S ^a   Jovanovic M ^b   Lavadinovic L ^b   Stosovic B ^b   Pelemis M ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Institute for Infectious and Tropical Diseases   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; GENTAMICIN;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BIOFILM; BLOOD PRESSURE; CASE REPORT; ENDOCARDITIS; ENTEROCOCCUS; ENTEROCOCCUS DURANS; GREAT VESSELS TRANSPOSITION; HEMOLYSIS; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 1542614247     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05382-0     Document Type: Article

References (17)

1. Connelly, M. S., Liu, P. P., Williams, W. G., Webb, G. D., Robertson, P. & McLaughlin, P. R. (1996). Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol 27, 1238-1243.
2. Coque, T. M., Patterson, J. E., Steckelberg, J. M. & Murray, B. E. (1995). Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis 171, 1223-1229.
3. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167-193.
4. Elsner, H.-A., Sobottka, I., Mack, D., Claussen, M., Laufs, R. & Wirth, R. (2000). Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis 19, 39-42.
5. Facklam, R. R. & Collins, M. D. (1989). Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27, 731-734.
6. Fuchs, P. C., Barry, A. L. & Brown, S. D. (1996). Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance Group. Diagn Microbiol Infect Dis 24, 213-219.
7. Johnson, A. P., Warner, M., Woodford, N., Speller, D. C. E. & Livermore, D. M. (1998). Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. BMJ 317, 629-630.
8. Knudtson, L. M. & Hartman, P. A. (1992). Routine procedures for isolation and identification of enterococci and fecal streptococci. Appl Environ Microbiol 58, 3027-3031.
9. Le, T. & Bayer, A. S. (2003). Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36, 615-621.
10. Mylonakis, E. & Calderwood, S. B. (2001). Infective endocarditis in adults. N Engl J Med 345, 1318-1330.
11. National Committee for Clinical Laboratory Standards (2002). Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. NCCLS document M100-S12. Wayne, PA: NCCLS.
12. Olaison, L. & Schadewitz, K. (2002). Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 34, 159-166.
13. Padilla, C., Brevis, P., Lobos, O., Hubert, E. & Zamorano, A. (2001). Production of antimicrobial substances, by hospital bacteria, active against other micro-organisms. J Hosp Infect 49, 43-47.
14. Stepanović, S., Vuković, D., Trajković, V., Samardžić, T., Ćupić, M. & Švabić- Vlahoví, M. (2001). Possible virulence factors of Staphylococcus sciuri. FEMS Microbiol Lett 199, 47-53.
15. Tripodi, M. F., Locatelli, A., Adinolfi, L. E., Andreana, A. & Utili, R. (1998). Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. Eur J Clin Microbiol Infect Dis 17, 734-736.
16. Vergis, E. N., Shankar, N., Chow, J. W., Hayden, M. K., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M. & Muder, R. R. (2002). Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcusfaecalis. Clin Infect Dis 35, 570-575.
17. Working Party of the British Society for Antimicrobial Chemotherapy (1998). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207-210.